Posts by Daniel B. Rubin, MD, PhD
-
Interim Safety Profile From the Feasibility Study of the BrainGate Neural Interface System
Massachusetts General Hospital researchers report that BrainGate, a brain–computer interface for people with paralysis, was not associated with any serious adverse event requiring device explantation, resulting in death or resulting in permanently increased disability during the one-year post-implantation period.
-
New Tool Identifies Risk of Neurotoxicity After CAR T-cell Therapy
A new scoring system identifies patients at higher risk of neurotoxicity after CAR T-cell therapy, which may prevent the need for routine prolonged hospitalization for observation.
-
EEG Can Be Used to Predict Successful Weaning from Anesthetics in Refractory Status Epilepticus
Quantitative measures of functional connectivity on continuous EEG predicted success in weaning patients with refractory status epilepticus from intravenous anesthetics.
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.